Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1085412-35-6

Post Buying Request

1085412-35-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1085412-35-6 Usage

General Description

4-(2-(tert-butoxycarbonylamino)ethoxy)pyridine-2,6-dicarboxylic acid is a chemical compound that is a derivative of pyridine-2,6-dicarboxylic acid with an additional tert-butoxycarbonylaminoethyl group attached to the pyridine ring. 4-(2-(tert-butoxycarbonylaMino)ethoxy)pyridine-2,6-dicarboxylic acid has potential applications in the field of medicinal chemistry and drug development due to its unique structure and potential biological activities. It may be used as a building block or intermediate in the synthesis of pharmaceutical compounds or as a ligand in coordination chemistry. The presence of the tert-butoxycarbonylamino group could also impart specific properties or functionalities to this compound, making it a potentially valuable chemical for research and industrial applications.

Check Digit Verification of cas no

The CAS Registry Mumber 1085412-35-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,8,5,4,1 and 2 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1085412-35:
(9*1)+(8*0)+(7*8)+(6*5)+(5*4)+(4*1)+(3*2)+(2*3)+(1*5)=136
136 % 10 = 6
So 1085412-35-6 is a valid CAS Registry Number.

1085412-35-6Relevant articles and documents

Pyridostatins selectively recognize two different forms of the human telomeric G-quadruplex structures and their anti-tumor activities in vitro

Wang, Li-Xia,Shang, Qian,Li, Qian,Xiang, Jun-Feng,Liu, Yan,Guan, Ai-Jiao,Sun, Hong-Xia,Yu, Li-Jia,Tang, Ya-Lin

, p. 4982 - 4986 (2015)

G-quadruplex as a therapeutic target to develop novel anti-cancer agents has attracted a growing interest. Among all the ligands of G-quadruplexes, pyridostatin derivatives play a very important role. Here, we first reported the recognition of the fundamental skeleton pyridostatin I, which was simply synthesized. Compared to pyridostatin II comprising terminal amino groups, pyridostatin I selectively stabilized intramolecular anti-parallel telomeric G-quadruplex by raising the melting temperature about 20 °C at 295 nm of H22, while pyridostatin II preferred to stabilize intermolecular parallel telomeric G-quadruplex by raising the melting temperature about 25 °C at 265 nm of H7, maybe due to the suited size measurements between G-quadruplex hosts and pyridostatin guests. MTT assays indicated that pyridostatin II had better cytotoxic effects against HCT-8 and A549 cell lines obviously, indicating positively charged side chains may be required for improving the water solubility and cellular uptake of the apolar central skeleton.

A novel small molecule that alters shelterin integrity and triggers a DNA-damage response at telomeres

Rodriguez, Raphael,Mueller, Sebastian,Yeoman, Justin A.,Trentesaux, Chantal,Riou, Jean-Francois,Balasubramanian, Shankar

, p. 15758 - 15759 (2008)

We describe a novel synthetic small molecule which shows an unprecedented stabilization of the human telomeric G-quadruplex with high selectivity relative to double-stranded DNA. We report that this compound can be used in vitro to inhibit telomerase activity and to uncap human POT1 (protection of telomeres 1) from the telomeric G-overhang. We also show that the small molecule G-quadruplex binder induces a partial alteration of shelterin through POT1 uncapping from telomeres in human HT1080 cancer cells and the presence of γH2AX foci colocalized at telomeres. Copyright

Pyridostatin analogues promote telomere dysfunction and long-term growth inhibition in human cancer cells

Müller, Sebastian,Sanders, Deborah A.,Di Antonio, Marco,Matsis, Stephanos,Riou, Jean-Fran?ois,Rodriguez, Rapha?l,Balasubramanian, Shankar

supporting information; experimental part, p. 6537 - 6546 (2012/09/08)

The synthesis, biophysical and biological evaluation of a series of G-quadruplex interacting small molecules based on a N,N′-bis(quinolinyl) pyridine-2,6-dicarboxamide scaffold is described. The synthetic analogues were evaluated for their ability to stabilize telomeric G-quadruplex DNA, some of which showed very high stabilization potential associated with high selectivity over double-stranded DNA. The compounds exhibited growth arrest of cancer cells with detectable selectivity over normal cells. Long-time growth arrest was accompanied by senescence, where telomeric dysfunction is a predominant mechanism together with the accumulation of restricted DNA damage sites in the genome. Our data emphasize the potential of a senescence-mediated anticancer therapy through the use of G-quadruplex targeting small molecules based on the molecular framework of pyridostatin.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1085412-35-6